Skip to content

Tempus AI, Inc. TEM Diagnostics — Revenue

Other product segments

Clinical Order
$239.3M+31.8%
Insights Product
$71.3M+44.0%
Genomics Product
$21.8M+77.2%
AI Applications
$20.1M
Trials Product
$9.9M+2.1%
Next Product
$5.7M

Similar metrics at other companies

Lantheus Holdings logo
LNTHUS — Revenue
$354.43M-0.9%
Lantheus Holdings logo
LNTHProduct — Revenue
$369.85M+0.8%
Labcorp Holdings logo
LHDiagnostics — Revenue
$2.76B+5.0%
Lantheus Holdings logo
LNTHDefinity — Revenue
$84.63M+6.8%
TEC
TECHDiagnostics And Spatial Biology — Revenue
$85.59M-4.1%
Danaher logo
DHRDiagnostics — Sales
$2.42B-1.3%

Other financials

Income statement

See full
Revenue$348.1M+36.1%
Operating income-$84.7M-23.3%
Net income-$125.9M-85.1%
EPS (diluted)-$0.71-77.5%

Balance sheet

See full
Cash & equivalents$525.9M+243%
Total debt$85.4M+49.8%
Total equity$416.4M+27.7%
Total assets$2.1B+38.4%

Cash flow

See full
Operating cash flow-$73.3M+30.6%
CapEx$8.2M+295%
Free cash flow-$81.5M+24.3%

Valuation

See full
Market cap$9.13B-2.7%
Enterprise value$8.69B-6.9%
P/S6.7×-5.0×

Profitability

See full
Operating margin-19.7%-8.6pp
Net margin-22.2%-9.5pp
FCF margin-54.5%

Returns & leverage

See full
Return on equity-81.6%
Debt / equity0.2×0.0×
Current ratio3.3×+1.6×

Where this comes from

Reported directly by Tempus AI, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Tempus AI, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tempus AI, Inc.'s diagnostics — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tempus AI, Inc.'s diagnostics — revenue?
Tempus AI, Inc. (TEM) reported diagnostics — revenue of $261.1M in Q1 2026.
How has Tempus AI, Inc.'s diagnostics — revenue changed year-over-year?
Tempus AI, Inc.'s diagnostics — revenue increased by 34.7% year-over-year, from $193.8M to $261.1M.
What does diagnostics — revenue mean?
This metric represents the total gross revenue generated from the sale of diagnostic testing services and associated data-driven insights, excluding any collected sales or excise taxes. It serves as the primary indicator of market adoption and commercial scale for the company's diagnostic product line. This figure reflects the value delivered to healthcare providers and clinical institutions through the company's proprietary testing platform.